Besra
Gurdyal Besra, Birmingham GB
Patent application number | Description | Published |
---|---|---|
20120034269 | ANALOGS OF ALPHA GALACTOSYLCERAMIDE AND USES THEREOF - Compounds of formula | 02-09-2012 |
20120269857 | ANALOGS OF ALPHA GALACTOSYLCERAMIDE AND USES THEREOF - Compounds of formula | 10-25-2012 |
Gurdyal S. Besra, West Midlands GB
Patent application number | Description | Published |
---|---|---|
20100310585 | THE USE OF MONOMYCOLYL GLYCEROL (MMG) AS AN ADJUVANT - Here we identify MMG and its alpha- and ketomycolic acid derivatives as highly bioactive lipids derived from | 12-09-2010 |
20140348786 | BETA-MANNOSYLCERAMIDE AND STIMULATION OF NKT CELL ANTI-TUMOR IMMUNITY - β-mannosylceramides or salts or solvates thereof in a pharmaceutically acceptable carrier, for use as a Type I NKT cell agonist in conjunction with a therapeutically effective amount of α-galactosylceramide or a salt or a solvate thereof, and/or at least one or more T-cell co-stimulatory molecules, disclosed. Compositions comprising β-mannosylceramide, as well as methods of treatment of tumors are also provided. | 11-27-2014 |
Gurdyal S. Besra, Birmingham GB
Patent application number | Description | Published |
---|---|---|
20100279324 | Assay For Detecting Mycobacterial Infection - Methods for assessing a mycobacterial infection in a subject comprise exposing at least one CD1 molecule or analogue to mycolic acid or a mycolic acid analogue, subsequently incubating the at least one CD1 molecule or analogue with a sample comprising at least one T cell isolated from the subject, and measuring the T cell response and/or the number of mycolic acid specific T cells present in the T cell sample. | 11-04-2010 |
Gurdyal S. Besra, Solihull GB
Patent application number | Description | Published |
---|---|---|
20130039886 | BETA-MANNOSYLCERAMIDE AND STIMULATION OF NKT CELL ANTI-TUMOR IMMUNITY - β-mannosylceramides or salts or solvates thereof in a pharmaceutically acceptable carrier, for use as a Type I NKT cell agonist in conjunction with a therapeutically effective amount of α-galactosylceramide or a salt or a solvate thereof, and/or at least one or more T-cell co-stimulatory molecules, disclosed. Compositions comprising β-mannosylceramide, as well as methods of treatment of tumors are also provided. | 02-14-2013 |